| Androgen receptor signaling inhibitors in addition to docetaxel with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: a systematic review and meta … T Yanagisawa, P Rajwa, C Thibault, G Gandaglia, K Mori, T Kawada, ... European urology 82 (6), 584-598, 2022 | 56 | 2022 |
| En Bloc Resection for Bladder Tumors: An Updated Systematic Review and Meta-Analysis of Its Differential Effect on Safety, Recurrence and Histopathology T Yanagisawa, K Mori, RS Motlagh, T Kawada, H Mostafaei, F Quhal, ... The Journal of Urology 207 (4), 754-768, 2022 | 36 | 2022 |
| Diagnostic performance of prostate-specific membrane antigen positron emission tomography–targeted biopsy for detection of clinically significant prostate cancer: a systematic … T Kawada, T Yanagisawa, P Rajwa, RS Motlagh, H Mostafaei, F Quhal, ... European urology oncology 5 (4), 390-400, 2022 | 34 | 2022 |
| Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis T Yanagisawa, K Mori, S Katayama, H Mostafaei, F Quhal, E Laukhtina, ... International Journal of Clinical Oncology, 1-13, 2022 | 24 | 2022 |
| Vertical lamina propria invasion diagnosed by en bloc transurethral resection is a significant predictor of progression for pT1 bladder cancer T Yanagisawa, J Miki, T Yorozu, K Iwatani, K Obayashi, S Sato, T Kimura, ... The Journal of Urology 205 (6), 1622-1628, 2021 | 23 | 2021 |
| Feasibility and accuracy of pathological diagnosis in en‐bloc transurethral resection specimens versus conventional transurethral resection specimens of bladder tumour … T Yanagisawa, T Yorozu, J Miki, K Iwatani, K Obayashi, S Sato, T Kimura, ... Histopathology 78 (7), 943-950, 2021 | 23 | 2021 |
| Anatomical localization and clinical impact of sentinel lymph nodes based on patterns of pelvic lymphatic drainage in clinically localized prostate cancer J Miki, T Yanagisawa, S Tsuzuki, K Mori, F Urabe, S Kayano, T Yorozu, ... The Prostate 78 (6), 419-425, 2018 | 23 | 2018 |
| Differential efficacy of ablation therapy versus partial nephrectomy between clinical T1a and T1b renal tumors: a systematic review and meta-analysis T Yanagisawa, K Mori, T Kawada, RS Motlagh, H Mostafaei, F Quhal, ... Urologic Oncology: Seminars and Original Investigations 40 (7), 315-330, 2022 | 22 | 2022 |
| Clinical significance of horizontal and vertical margin of en bloc resection for nonmuscle invasive bladder cancer T Yanagisawa, J Miki, K Sakanaka, W Fukuokaya, K Iwatani, S Sato, ... The Journal of Urology 206 (2), 252-259, 2021 | 20 | 2021 |
| Do we need repeat transurethral resection after en bloc resection for pathological T1 bladder cancer? T Yanagisawa, S Sato, Y Hayashida, Y Okada, K Iwatani, A Matsukawa, ... BJU international 131 (2), 190-197, 2023 | 18 | 2023 |
| Effectiveness of pembrolizumab in patients with urothelial carcinoma receiving proton pump inhibitors W Fukuokaya, T Kimura, K Komura, T Uchimoto, K Nishimura, ... Urologic Oncology: Seminars and Original Investigations 40 (7), 346. e1-346. e8, 2022 | 18 | 2022 |
| Intensification of systemic therapy in addition to definitive local treatment in nonmetastatic unfavourable prostate cancer: a systematic review and meta-analysis P Rajwa, B Pradere, G Gandaglia, RCN van den Bergh, I Tsaur, SR Shim, ... European Urology 82 (1), 82-96, 2022 | 17 | 2022 |
| HER2 status in molecular subtypes of urothelial carcinoma of the renal pelvis and ureter T Yorozu, S Sato, T Kimura, K Iwatani, H Onuma, T Yanagisawa, J Miki, ... Clinical Genitourinary Cancer 18 (4), e443-e449, 2020 | 17 | 2020 |
| Hematological prognosticators in metastatic renal cell cancer treated with immune checkpoint inhibitors: A meta-analysis T Yanagisawa, K Mori, S Katayama, H Mostafaei, F Quhal, E Laukhtina, ... Immunotherapy 14 (9), 709-725, 2022 | 15 | 2022 |
| Comparison of clinicopathologic and oncological outcomes between transurethral en bloc resection and conventional transurethral resection of bladder tumor: a systematic review … R Sari Motlagh, P Rajwa, K Mori, E Laukhtina, A Aydh, S Katayama, ... Journal of Endourology 36 (4), 535-547, 2022 | 15 | 2022 |
| The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy K Obayashi, J Miki, W Fukuokaya, T Yanagisawa, S Kimura, S Tsuzuki, ... International journal of clinical oncology, 1-7, 2022 | 15 | 2022 |
| Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes E Laukhtina, RS Motlagh, K Mori, S Katayama, P Rajwa, T Yanagisawa, ... Critical Reviews in Oncology/Hematology 169, 103570, 2022 | 15 | 2022 |
| Oncologic and safety outcomes for endoscopic surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: an updated systematic review and meta-analysis T Kawada, E Laukhtina, F Quhal, T Yanagisawa, P Rajwa, M Pallauf, ... European Urology Focus 9 (2), 236-240, 2023 | 14 | 2023 |
| The effect of immune checkpoint inhibitor combination therapies in metastatic renal cell carcinoma patients with and without previous cytoreductive nephrectomy: a systematic … K Mori, F Quhal, T Yanagisawa, S Katayama, B Pradere, E Laukhtina, ... International Immunopharmacology 108, 108720, 2022 | 14 | 2022 |
| The efficacy and safety of metastasis-directed therapy in patients with prostate cancer: a systematic review and meta-analysis of prospective studies M Miszczyk, P Rajwa, T Yanagisawa, Z Nowicka, SR Shim, E Laukhtina, ... European Urology, 2023 | 12 | 2023 |
